Eugenio Barone

Pubblicazioni

Titolo Pubblicato in Anno
Editorial: Brain insulin resistance in neurodevelopmental and neurodegenerative disorders: mind the gap! FRONTIERS IN NEUROSCIENCE 2021
Valorization of tomato waste as a source of carotenoids MOLECULES 2021
Building the future therapies for down syndrome: the third international conference of the T21 research society MOLECULAR SYNDROMOLOGY 2021
Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome NEUROBIOLOGY OF DISEASE 2020
Heme oxygenase-1 in central nervous system malignancies JOURNAL OF CLINICAL MEDICINE 2020
Down syndrome Is a metabolic disease: altered Insulin signaling mediates peripheral and brain dysfunctions FRONTIERS IN NEUROSCIENCE 2020
Circulating dipeptidyl peptidase-4 is independently associated with the presence and severity of NAFLD/NASH in individuals with and without obesity and metabolic disease JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2020
The BACH1/Nrf2 axis in brain in down syndrome and transition to alzheimer disease-like neuropathology and dementia ANTIOXIDANTS 2020
Chronic perk induction promotes alzheimer-like neuropathology in down syndrome: Insights for therapeutic intervention PROGRESS IN NEUROBIOLOGY 2020
Reduced biliverdin reductase-a expression in visceral adipose tissue is associated with adipocyte dysfunction and nafld in human obesity INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2020
The dysregulation of OGT/OGA cycle mediates Tau and APP neuropathology in down syndrome NEUROTHERAPEUTICS 2020
Proteomics study of peripheral blood mononuclear cells in down syndrome children ANTIOXIDANTS 2020
BVR-A deficiency leads to autophagy impairment through the dysregulation of AMPK/mTOR axis in the brain—Implications for neurodegeneration ANTIOXIDANTS 2020
Biliverdin reductase-A mediates the beneficial effects of intranasal insulin in Alzheimer disease MOLECULAR NEUROBIOLOGY 2019
Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease NEUROBIOLOGY OF DISEASE 2019
Reduced biliverdin reductase-a levels are associated with early alterations of insulin signaling in obesity BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR BASIS OF DISEASE 2019
Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome REDOX BIOLOGY 2019
Greater circulating DPP4 activity is associated with impaired flow-mediated dilatation in adults with type 2 diabetes mellitus NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES 2019
Early and selective activation and subsequent alterations to the unfolded protein response in down syndrome mouse models JOURNAL OF ALZHEIMER'S DISEASE 2018
Disturbance of redox homeostasis in down syndrome: role of iron dysmetabolism FREE RADICAL BIOLOGY & MEDICINE 2018

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma